|
Volumn 100, Issue 12, 2015, Pages L126-L127
|
Letter to the editor: "Steroid sex hormones, sex hormone-binding globulin, and diabetes incidence in the diabetes prevention program" by Mather K.J., et al
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ESTRADIOL;
ESTROGEN;
ESTROGEN SULFOTRANSFERASE;
ESTRONE;
FOLLITROPIN;
GLUCOSE;
LUTEINIZING HORMONE;
SEX HORMONE BINDING GLOBULIN;
STEROID;
ANDROGEN;
CROSS-SECTIONAL STUDY;
CYP19 GENE;
DIABETES CONTROL;
DIABETES MELLITUS;
DISEASE PREDISPOSITION;
DRUG EFFICACY;
DRUG RESPONSE;
ESTROGEN BLOOD LEVEL;
ESTROGEN DEFICIENCY;
ESTROGEN THERAPY;
FOLLITROPIN BLOOD LEVEL;
GENE MUTATION;
GLUCOSE BLOOD LEVEL;
GLUCOSE INTOLERANCE;
HORMONE RESISTANCE;
HORMONE RESPONSE;
HUMAN;
INCIDENCE;
INSULIN RESISTANCE;
LETTER;
LUTEINIZING HORMONE BLOOD LEVEL;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ONCOGENE;
PATHOGENESIS;
PRIORITY JOURNAL;
RISK FACTOR;
BLOOD;
DIABETES MELLITUS, TYPE 2;
FEMALE;
MALE;
METABOLISM;
ANDROGENS;
DIABETES MELLITUS, TYPE 2;
ESTROGENS;
FEMALE;
HUMANS;
MALE;
SEX HORMONE-BINDING GLOBULIN;
|
EID: 84950993880
PISSN: 0021972X
EISSN: 19457197
Source Type: Journal
DOI: 10.1210/jc.2015-3755 Document Type: Letter |
Times cited : (1)
|
References (8)
|